Successful clinical response to irinotecan in relapsed neuroblastoma.
Shitara
Toshiji
T
Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan.
Shimada
Akira
A
Tsuchida
Yoshiaki
Y
Suzuki
Norio
N
Toki
Fumiaki
F
Kuroiwa
Minoru
M
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009447:Neuroblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography; D016879:Salvage Therapy; D059004:Topoisomerase I Inhibitors; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002166:Camptothecin